View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Dr. Jens Lundgren discusses results from key studies reported at the IAS COVID-19 Conference: Prevention, including new findings on potential SARS-CoV-2 suppressive therapies, strategies for vaccination and mass testing, and interventions to prevent transmission of COVID-19 while maintaining desired outcomes in HIV care.
Jens D. Lundgren, MD, DMSc
Professor
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Clinical Care Options (CCO) expert analysis of new data from CROI 2021, provided by expert HIV faculty
Joseph J. Eron, Jr., MD
Princy N. Kumar, MD, FIDSA, MACP
Eric S. Daar, MD
Renslow Sherer, MD
Released: May 10, 2021
Clinical Care Options (CCO) podcast with Dr William Short on current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV
William R. Short, MD, MPH, AAHIVS
Released: May 7, 2021
Clinical Care Options (CCO) presents Howard Grossman, MD, and Cristina Mussini, MD, answering questions on HIV prevention in older individuals
Howard Grossman, MD
Cristina Mussini, MD
Released: May 6, 2021
Clinical Care Options (CCO) expert Dr. Yasuhito Tanaka on HCC risk prediction in patients with chronic hepatitis B using the novel serum biomarker HBcrAg
Yasuhito Tanaka, MD, PhD
Released: May 6, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.